|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/17 | (2013.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61K 38/1767 | (2013.01) |
| (11) | Patento numeris | 3151851 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15728491.0 |
| Europos patento paraiškos padavimo data | 2015-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/062742 |
| Data | 2015-06-08 |
| (87) | Numeris | WO 2015/185760 |
| Data | 2015-12-10 |
| (30) | Numeris | Data | Šalis |
| 201410116 | 2014-06-06 | GB |
| (72) |
WESTON-DAVIES, Wynne H , GB
|
| (73) |
Volution Immuno Pharmaceuticals SA ,
Place Des Eaux Vives 6,, 3461-1211 Geneve 3,
CH
|
| (54) | ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN PATIENTS WITH C5 POLYMORPHISM |
| ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN PATIENTS WITH C5 POLYMORPHISM |